
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd reported quarterly revenue of $3.4 million for Q3, reflecting an increase from $3.0 million in the previous quarter, primarily driven by enhanced teleradiology utilization and improved margins. The company reaffirmed its goal to exceed 100 deployed units globally by year-end and provided a 2026 revenue guidance of $35 million, indicating confidence in unit placement and monetization across various revenue channels. Additionally, a strategic partnership with 3DR Labs positions Nanox.AI to access over 1,800 hospitals and imaging centers in the U.S., significantly expanding its commercial footprint and enhancing the potential for growth in its revolutionary imaging ecosystem.
Bears say
Nano X Imaging Ltd has experienced a significant decline in cash reserves, shrinking from $83.2 million at year-end to $55.5 million, primarily due to a substantial operating cash burn of $30.4 million. The company has been continuously lowering its revenue growth expectations over the past year, indicating ongoing challenges in achieving profitability. Additionally, the elevated GAAP gross loss of $2.9 million, coupled with a stable net loss of $13.7 million, highlights persistent financial strain despite heavy investments in system deployments and AI infrastructure.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares